Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02494752
What this trial is testing

Role of Mesenchymal Stem Cells in Fat Grafting

Who this might be right for
Romberg's DiseaseCraniofacial MicrosomiaLipodystrophy+1 more
King Edward Medical University 30
Very early researchStudy completedNCT02331706
What this trial is testing

IFN-DLI for Relapsed Acute Leukemia After Allo-SCT

Who this might be right for
Leukemia
Abramson Cancer Center at Penn Medicine 16
Early research (Phase 1)WithdrawnNCT05589844
What this trial is testing

A Cytomegalovirus-Directed Vaccine (CMV-alphaDC1) for Preventing Cytomegalovirus Infection or Reactivation in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cytomegaloviral InfectionHematopoietic and Lymphoid System Neoplasm
Roswell Park Cancer Institute
Large-scale testing (Phase 3)UnknownNCT03389919
What this trial is testing

Intraosseous Administration of Mesenchymal Stromal Cells for Patients With Graft Failure After Allo-HSCT

Who this might be right for
Mesenchymal Stem Cell Transplantation
National Research Center for Hematology, Russia 20
Testing effectiveness (Phase 2)UnknownNCT05858814
What this trial is testing

RC1012 Injection (Allo-DNT Cells) for the Prevention of Relapse in AML Patients After Allo-HSCT

Who this might be right for
Acute Myeloid Leukemia
Guangdong Ruishun Biotech Co., Ltd 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT06075706
What this trial is testing

Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease

Who this might be right for
Steroid-refractory Acute Graft-versus-host Disease
medac GmbH 49
Testing effectiveness (Phase 2)UnknownNCT03336632
What this trial is testing

Chidamide Plus PTCy/Cyclosporine to Prevent GVHD After Myeloablative Conditioning, Matched PBSCT

Who this might be right for
Leukemia, AcuteMDS
Sichuan University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04554914
What this trial is testing

Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

Who this might be right for
Epstein-Barr Virus (EBV)-Associated DiseasesEBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD)EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD)+8 more
Pierre Fabre Medicament
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06598384
What this trial is testing

VA as Maintenance Therapy Post Allo-HSCT in MDS and AML

Who this might be right for
Acute Myeloid Leukemia
Navy General Hospital, Beijing 40
Early research (Phase 1)Study completedNCT00374933
What this trial is testing

Enhancing Graft vs Leukemia Via Delayed Ex-Vivo Co-Stimulated DLI After Non-Myeloablative Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Abramson Cancer Center at Penn Medicine 18
Testing effectiveness (Phase 2)UnknownNCT00702247
What this trial is testing

Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi)

Who this might be right for
Multiple Myeloma
Azienda Ospedaliera San Giovanni Battista
Testing effectiveness (Phase 2)Active Not RecruitingNCT05130827
What this trial is testing

Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT)

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 17
Early research (Phase 1)Study completedNCT03315741
What this trial is testing

The Safety and Tolerability of Pirfenidone for BOS After HCT

Who this might be right for
Bronchiolitis ObliteransGraft Vs Host Disease
Stanford University 30
Large-scale testing (Phase 3)Ended earlyNCT02999854
What this trial is testing

Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 63
Testing effectiveness (Phase 2)Study completedNCT00006241
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01078441
What this trial is testing

Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant

Who this might be right for
Refractory Multiple Myeloma
National Cancer Institute (NCI) 2
Early research (Phase 1)Study completedNCT01633229
What this trial is testing

Bone Marrow Stromal Cell Infusions for Stem Cell Transplant Complications

Who this might be right for
Graft-Versus-Host Disease
National Heart, Lung, and Blood Institute (NHLBI) 10
Testing effectiveness (Phase 2)Looking for participantsNCT07249346
What this trial is testing

Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaMyelodysplasiaChronic Myelomonocytic Leukemia
Hannah Choe, MD 124
Testing effectiveness (Phase 2)Study completedNCT05471661
What this trial is testing

T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation

Who this might be right for
Opportunistic Fungal InfectionOpportunistic Viral InfectionBone Marrow Transplant Infection
George Papanicolaou Hospital 10
Post-approval studies (Phase 4)UnknownNCT05926063
What this trial is testing

Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia

Who this might be right for
Neutropenia, Febrile
Universitaire Ziekenhuizen KU Leuven 410
Next Page
190